MLchartDataset catalogue

Pomalyst

Term · Oncology and biomedicine · MLC-T-ONC-006815

A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of multiple myeloma or Kaposi sarcoma. It is also being studied in the treatment of other types of cancer. Pomalyst may help the immune system kill cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. Pomalyst is a type of immunomodulating agent and a type of antiangiogenesis agent. Also called CC-4047 and pomalidomide.

Table 1. Record
IdentifierMLC-T-ONC-006815
FieldOncology and biomedicine
SynonymsCC-4047; pomalidomide
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006815",
  "term": "Pomalyst",
  "field": "Oncology and biomedicine",
  "definition": "A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of multiple myeloma or Kaposi sarcoma. It is also being studied in the treatment of other types of cancer. Pomalyst may help the immune system kill cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. Pomalyst is a type of immunomodulating agent and a type of antiangiogenesis agent. Also called CC-4047 and pomalidomide.",
  "synonyms": [
    "CC-4047",
    "pomalidomide"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pomalyst/"
}

Record 13,481 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.